Batten disease (Spielmeyer-Sjøgren disease) and haptoglobins (HP): indication of linkage and assignment to chr. 16

scientific article published on 01 October 1989

Batten disease (Spielmeyer-Sjøgren disease) and haptoglobins (HP): indication of linkage and assignment to chr. 16 is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1399-0004.1989.TB03193.X
P698PubMed publication ID2805379

P2093author name stringH Eiberg
R M Gardiner
J Mohr
P433issue4
P304page(s)217-218
P577publication date1989-10-01
P1433published inClinical GeneticsQ5133760
P1476titleBatten disease (Spielmeyer-Sjøgren disease) and haptoglobins (HP): indication of linkage and assignment to chr. 16
P478volume36

Reverse relations

cites work (P2860)
Q36497992A yeast model for the study of Batten disease
Q34386791Advances in the genetics of progressive myoclonus epilepsy
Q34427575Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses
Q73569851Epilepsy (update)
Q73573204Gene table: epilepsy
Q40865085Genetic analysis of Batten disease
Q35194995Genetic heterogeneity in neuronal ceroid lipofuscinosis (NCL): evidence that the late-infantile subtype (Jansky-Bielschowsky disease; CLN2) is not an allelic form of the juvenile or infantile subtypes
Q34804508Genetics of epilepsy: current status and perspectives.
Q41626530Hereditary epilepsy syndromes.
Q41496851Linkage disequilibrium between the juvenile neuronal ceroid lipofuscinosis gene and marker loci on chromosome 16p 12.1.
Q35194242Localization of juvenile, but not late-infantile, neuronal ceroid lipofuscinosis on chromosome 16
Q47439293Low molecular weight urinary peptides in ceroid-lipofuscinoses: Potential biochemical markers for the juvenile subtype
Q28506323Motor neuron degeneration of mice is a model of neuronal ceroid lipofuscinosis (Batten's disease)
Q60672829Neuronal ceroid lipofuscinoses (NCL)
Q34238598Positional cloning of the JNCL gene, CLN3.
Q36075070Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects
Q57252332Refined genetic mapping of juvenile-onset neuronal ceroid-lipofuscinosis on chromosome 16
Q24670091Regional mapping of the Batten disease locus (CLN3) to human chromosome 16p12
Q24678552Spectrum of mutations in the Batten disease gene, CLN3
Q90377163The CLN3 gene and protein: What we know
Q35624955The human genome: a prospect for paediatrics
Q37944570Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses

Search more.